JMSFF yields 36.90% · JNJ yields 2.14%● Live data
📍 JMSFF pulled ahead of the other in Year 1
Combined, JMSFF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JMSFF + JNJ for your $10,000?
James Fisher and Sons plc provides marine and specialist engineering services worldwide. It operates through four segments: Marine Support, Specialist Technical, Offshore Oil, and Tankships. The company engages in the provision of ship-to-ship transfer services, aerospace engineering, fabrication, design and engineering hazardous area, marine projects, mechanical and electrical and designs, and specialist engineering and structures consultancy designs; provides inspection and monitoring services, such as condition monitoring, construction plant products, onshore geotechnical, hull stress, load cells, marine and offshore safety systems, non-destructive testing, nuclear plants, offshore wind management, PyroSentry, radiation detection equipment, strain rings, structural, and X-ray inspection systems; and offers lifting and handling services, including container weight systems, crane overload monitoring, hose and umbilical reelers, lifting equipment, load links and shackles, marine cranes, and winches and hoists. It offers marine services, which include digital solutions, fuels infrastructure, installation and commission, offshore personnel and wind management, operation and maintenance, ship agency, shoreside support, site and surface preparation, and vessel chartering services; anchor an chain monitoring, deck and mooring equipment, fendering and flotation, and mooring and towing load monitoring; building infrastructure and services, containerized systems, engineered containments, manipulators and tooling, mechanical and remote handling, radiation tolerant equipment, and remote inspection systems; and subsea equipment and submarine rescue products. In addition, it operates ports in Plymouth, the United Kingdom. James Fisher and Sons Plc was founded in 1847 and is headquartered in Barrow-in-Furness, the United Kingdom.
Full JMSFF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.